KIMBERLY DOWNEY: Open Payments
NPI 1356706220 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,566 in 101 payments from 19 companies in 2025. Trend: 2023 $1,701 · 2024 $2,048 · 2025 $1,566
Food & beverage: $1,566
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $314 |
| Novo Nordisk Inc | 15 | $245 |
| AstraZeneca Pharmaceuticals LP | 8 | $206 |
| Lilly USA, LLC | 19 | $172 |
| Axsome Therapeutics, Inc. | 5 | $108 |
| PFIZER INC. | 5 | $91 |
| Astellas Pharma US Inc | 3 | $91 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Abbott Laboratories | 3 | $66 |
| Amgen Inc. | 3 | $45 |
Products named: AIRSUPRA, JARDIANCE, Ozempic, MOUNJARO, Veozah, Rybelsus, Auvelity, VRAYLAR.
Industry payments across SC — which companies pay providers there.
